Deborah Dunsire.
Littlehales
Crispin
C
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001702:Biopharmaceutics / Q000266:history / Q000458:organization & administration; D001709:Biotechnology / Q000266:history / Q000458:organization & administration*; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D004345:Drug Industry / Q000266:history / Q000458:organization & administration*; D016520:Entrepreneurship; D049674:History, 21st Century; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy; D009937:Organizational Objectives; D011719:Pyrazines / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib